日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-world post-2020 first-line maintenance treatment patterns in patients with advanced ovarian cancer in the US

美国晚期卵巢癌患者2020年后的真实世界一线维持治疗模式

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2526273
Chase, Dana M; Kalilani, Linda; Cooney, Maureen A; Kiss, Zsofia; Golembesky, Amanda K; Kobayashi, Monica; Dayma, Megha; Coskuncay, Elif; Schilder, Jeanne M
肿瘤
肿瘤免疫
卵巢癌
发表日期：2025
文献求助 收藏

Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study

COMB1NE 研究中接受尼拉帕尼联合贝伐珠单抗一线维持治疗的上皮性卵巢癌患者的特征和真实世界结局

期刊:International Journal of Gynecological Cancer
影响因子:4.7
doi:10.1136/ijgc-2024-005611
Thaker, Premal H; Areli Calderón Boyle, Tirza; Burns, Sara; Lim, Jonathan; Hartman, John; Kalilani, Linda V; Schilder, Jeanne M; Hurteau, Jean A; Golembesky, Amanda K
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Real-world overall survival in second-line maintenance niraparib monotherapy versus active surveillance in patients with BRCA wild-type recurrent ovarian cancer

在BRCA野生型复发性卵巢癌患者中，二线维持尼拉帕尼单药治疗与积极监测的真实世界总生存期比较

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359241292272
Coleman, Robert L; Perhanidis, Jessica A; Kalilani, Linda; Zimmerman, Nicole M; Golembesky, Amanda; Moore, Kathleen N
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study

真实世界中化疗联合贝伐单抗治疗后一线维持治疗尼拉帕尼单药治疗的应用：SW1TCH 研究

期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-024-00281-8
Rimel, Bobbie; Boyle, Tirza Areli Calderón; Burns, Sara; Lim, Jonathan; Hartman, John; Kalilani, Linda; Schilder, Jeanne M; Hurteau, Jean A; Golembesky, Amanda
发表日期：2024
文献求助 收藏

Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections

阿莫地喹和哌喹在患有无并发症恶性疟原虫感染的非洲孕妇中的群体药代动力学研究

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13211
Ding, Junjie; Hoglund, Richard M; Tagbor, Harry; Tinto, Halidou; Valéa, Innocent; Mwapasa, Victor; Kalilani-Phiri, Linda; Van Geertruyden, Jean-Pierre; Nambozi, Michael; Mulenga, Modest; Hachizovu, Sebastian; Ravinetto, Raffaella; D'Alessandro, Umberto; Tarning, Joel
炎症/感染
发表日期：2024
文献求助 收藏

The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis

卵巢癌患者行细胞减灭术后残留病灶程度不同对生存结局的影响：一项荟萃分析

期刊:BMC Womens Health
影响因子:2.7
doi:10.1186/s12905-024-02977-5
Chase, Dana M; Mahajan, Anadi; Scott, David Alexander; Hawkins, Neil; Kalilani, Linda
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression

欧洲卵巢癌回顾性研究 (O'CaRE)：按进展风险因素数量划分的一线治疗结果

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2024.2402217
Krell, Jonathan; Shaw, Danielle; McGrane, John; Hartkopf, Andreas; Herrero, Ana; Yeoh, Cheng; Masvidal, Maria; Raspagliesi, Francesco; York, Whitney; Schilder, Jeanne M; Mascialino, Barbara; McDermott, Eleanor; Kalilani, Linda; Hanker, Lars
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Cytochrome P450 inhibitor/inducer treatment patterns among patients in the United States with advanced ovarian cancer who were prescribed or were eligible for poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitors in the first-line maintenance setting

美国晚期卵巢癌患者在接受一线维持治疗时，使用细胞色素P450抑制剂/诱导剂的治疗模式，这些患者要么被处方使用聚腺苷二磷酸[ADP]-核糖聚合酶抑制剂，要么符合使用此类抑制剂的条件。

期刊:Gynecologic Oncology Reports
影响因子:1.3
doi:10.1016/j.gore.2024.101332
Rimel, Bobbie J; Chase, Dana M; Perhanidis, Jessica; Ghazarian, Armen A; Du, Ella Xiaoyan; Wang, Travis; Song, Jinlin; Golembesky, Amanda K; Hurteau, Jean A; Kalilani, Linda; Salani, Ritu; Monk, Bradley J
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review

卵巢癌患者细胞减灭术后无进展生存期与总生存期的相关性：系统性文献综述

期刊:International Journal of Gynecological Cancer
影响因子:4.7
doi:10.1136/ijgc-2023-004487
Chase, Dana M; Mahajan, Anadi; Scott, David Alexander; Hawkins, Neil; Kalilani, Linda
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Sequential disruptions to inflammatory and angiogenic pathways and risk of spontaneous preterm birth in Malawian women

炎症和血管生成途径的连续中断与马拉维妇女自发性早产的风险

期刊:iScience
影响因子:4.6
doi:10.1016/j.isci.2023.106912
Andrea M Weckman, Robyn E Elphinstone, John M Ssenkusu, Vanessa Tran, Kathleen Zhong, Mwayiwawo Madanitsa, Carole Khairallah, Linda Kalilani-Phiri, Victor Mwapasa, Andrea L Conroy, Feiko O Ter Kuile, Chloe R McDonald, Kevin C Kain
心血管
Angiogenesis
发表日期：2023
文献求助 收藏